We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£109.91
This is the most expensive it has ever been. Walk away.
£110 today · previous high £110 · all-time low £107
Springer Resistance to Immunotherapeutic Antibodies in Cancer - Springer
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 72 days · 72 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 72 days • 3 price levels
Price Analysis
Most common price: £108 (45 days, 62.5%)
Price range: £107 - £110
Price levels: 3 different prices over 72 days
Description
Key Features
Focuses on monoclonal antibodies as selective anti-cancer agents that block specific cell receptors on malignant tumor cells.
Part 2 of the Resistance to Targeted Anti-Cancer Therapeutics series from Springer, offering advanced clinical insights.
Covers strategies to overcome immunotherapeutic resistance in cancer treatment protocols.
Examines less toxic alternatives to traditional chemotherapy and radiation approaches.
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 1489987320
- Domain
- Amazon UK
- Release Date
- 22 August 2015
- Listed Since
- 22 August 2015
Barcode
No barcode data available
Similar Products You Might Like
Resistance to Immunotherapeutic Antibodies in Cancer - Springer
Springer
Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
Elsevier
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
Humana
IL-1 in Cancer and Inflammation - Academic Press Medical Book
Elsevier
Nijkamp and Parnham's Principles of Immunopharmacology
Springer
Immune Aspects of Biopharmaceuticals and Nanomedicines (Jenny Stanford Series on Nanomedicine)
Taylor & Francis
Progress in Cancer Immunotherapy - Springer Medical Research
Springer
Cancer Immunotherapy: Immune Suppression and Tumor Growth
Elsevier
Elsevier Basic Immunology 7th Edition - Medical Text
Elsevier
Cancer Immunosurveillance: Methods and Protocols - Vol. 1884
Humana
Innate Immune Regulation and Cancer Immunotherapy - Springer
Springer
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
Springer
Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)
Humana
Cancer Immunotherapy: Immune Suppression and Tumor Growth
Elsevier
Regulatory B Cells: Methods and Protocols: 1190 (Methods in Molecular Biology)
Humana
Advances in Immunology Volume 86 - Academic Press
Elsevier
Targeted Cancer Immune Therapy
Springer
Immune Receptors: Methods and Protocols - Molecular Biology
Humana
Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)
Elsevier
Nitric Oxide and Cancer: Pathogenesis and Therapy
Springer
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
Springer
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)
Springer
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
Springer
Mathematical Modelling of Immune Response - Springer 395
Springer